Charles Morgan Kendrick JR - Mar 1, 2023 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Role
EVP & President, Commercial
Signature
/s/ Kathleen S. Kiefer, Attorney in fact
Stock symbol
ELV
Transactions as of
Mar 1, 2023
Transactions value $
-$645,583
Form type
4
Date filed
3/3/2023, 03:19 PM
Previous filing
Nov 3, 2022
Next filing
Mar 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELV Common Stock Tax liability -$137K -293 -2.03% $469.03 14.2K Mar 1, 2023 Direct F1
transaction ELV Common Stock Award $0 +2.03K +14.31% $0.00 16.2K Mar 1, 2023 Direct F2
transaction ELV Common Stock Award $0 +2.54K +15.71% $0.00 18.7K Mar 1, 2023 Direct F3
transaction ELV Common Stock Tax liability -$508K -1.08K -5.79% $468.78 17.6K Mar 2, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELV Employee Stock Option (Right to Buy) Award $0 +7.79K $0.00 7.79K Mar 1, 2023 Common Stock 7.79K $469.03 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
F2 Represents restricted share units. Restrictions lapse as follows: 675 shares each on 3/1/2024 and 3/1/2025 and 676 shares on 3/1/2026.
F3 Represents performance based restricted share units. Restrictions lapse on 3/2/2023.
F4 The option represents a right to purchase a total of 7,786 shares, and is exercisable in two installments of 2,595 shares each and one installment of 2,596 shares, beginning on 3/1/2024 which is the one-year anniversary of the option grant date.